LONDON (Reuters) - AstraZeneca's new cancer drug olaparib, which won a green light from European regulators last month for inherited ovarian cancer, could also be used much more widely to treat prostate cancer, according to a leading oncologist. Johann de Bono, professor of experimental cancer therapeutics at the Institute of Cancer Research in London, told a conference on Tuesday the drug had produced "encouraging" preliminary results in clinical tests against prostate cancer. ...
via Health News Headlines - Yahoo News http://ift.tt/1x3Y4HI
No comments:
Post a Comment